Rootpath Genomics

Developer of immunotherapy platform for the treatment of cancer

placeCambridge, Massachusetts, United States calendar_todayFounded 2017 groups16 employees language rootpath.com

Registered entities

Investor mix

10 investors on record; lead investors include Yuanhe Holdings, Sequoia Capital, CDH, Sky9 Capital.

Investor typeCountShare
Venture capital550%
Private equity220%
Accelerator & incubator110%
Other / undisclosed220%
Coming soon